This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Roche Diagnostics GmbH
Roche Diagnostics GmbH, a subsidiary of the Swiss multinational Roche Holding AG, is a leading player in the global healthcare industry, headquartered in Germany. Established in 1896, Roche Diagnostics has consistently innovated in the fields of in-vitro diagnostics and tissue-based cancer diagnostics, making significant strides in personalised healthcare. With a strong presence in Europe, North America, and Asia, Roche Diagnostics offers a diverse range of core products and services, including advanced diagnostic instruments, reagents, and software solutions. Their commitment to precision medicine and robust research and development has positioned them as a market leader, recognised for their unique contributions to disease detection and management. Notable achievements include pioneering advancements in molecular diagnostics and a comprehensive portfolio that supports healthcare professionals in delivering accurate and timely patient care. Roche Diagnostics continues to shape the future of diagnostics, enhancing patient outcomes worldwide.
DitchCarbon Score
How does Roche Diagnostics GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diagnostics GmbH's score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diagnostics GmbH, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and performance metrics. Roche Diagnostics GmbH inherits its climate initiatives and targets from Roche Holding AG, which has established science-based targets (SBTi) aimed at reducing greenhouse gas emissions. However, specific reduction targets or achievements for Roche Diagnostics GmbH are not detailed in the available data. As part of its commitment to sustainability, Roche Holding AG has implemented various initiatives to address climate change, although specific details regarding these initiatives at the subsidiary level remain unspecified. The absence of direct emissions data highlights the need for further transparency in reporting and commitment to climate action within the diagnostics sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 249,350,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 114,452,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,402,719,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Diagnostics GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
